Clinical Trial Update: Retrospective Study: Efficacy and Safety of Chlorambucil + Rituximab in CLL Patients

View source ↗

Summary

A retrospective study evaluated the efficacy and safety of chlorambucil plus rituximab in chronic lymphocytic leukemia patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Leukeran (chlorambucil)
• Rituxan (rituximab)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: CLL, B-cell | Status: UNKNOWN